[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002239:Carbohydrate Metabolism, Inborn Errors / Q000175:diagnosis* / Q000178:diet therapy; D002994:Clofibrate / Q000627:therapeutic use*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000178:diet therapy; D003937:Diagnosis, Differential; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications*; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009765:Obesity; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D014280:Triglycerides; D002994:Clofibrate
Zur Differentialdiagnose und Differentialtherapie der Kohlenhydrat-Toleranzstörungen bei Patienten mit Hyperlipoproteinämie. Verhalten der Plasmalipide, der Glukosetoleranz und von Plasmainsulin nach Glukosebehandlung während der Behandlung mit Clofibrat